- Goel P, Choudhury SR. Persistent hyperinsulinemic hypoglycemia of infancy: An overview of current concepts. J Indian Assoc Pediatr Surg. 2012; 17(3):99-103.
- Shilyansky J, Fisher S, Cutz E, Perlman K, Filler RM. Is 95% pancreatectomy the procedure of choice for treatment of persistent hyperinsulinemic hypoglycemia of the neonate? J Pediatr Surg. 1997; 32(2):342-6.
- Wahid F, Al Onazi M, Al Rawaf A, Al Muhaidly M, Al Otaibi A, Al Hudhaif J. Persistent hyperinsulinemic hypoglycemia of infancy: long-term follow-up after surgical treatment. Annal Pediatr Surg. 2013; 7(4):123-5.
- Harris JP, Ricker AT, Gray RS, Steed RD, Gutal JJ. Reversible hypertrophic cardiomyopathy associated with nesidioblastosis. J Pediatr. 1992; 120(2):272-5.
- Rizzo G, Arduini D, Romanini C. Accelerated cardiac growth and abnormal cardiac flow in fetuses of type I diabetic mothers. Obstet Gynecol. 1992; 80(3 Pt 1):369-76.
- Massin MM, Van Elmbt G, Soyeur D. Reversible hypertrophic cardiomyopathy in congenital hyperinsulinism. Acta cardiol. 1999; 54(6):359-61.
- Bulbul A, Bolat F, Comert S, Demirin H, Tanik C, Bulbul L, et al. Persistent hyperinsulinemic hypoglycemia with left ventricular hypertrophy and dysrhythmia: a case report. Fetal Pediatr Pathol. 2010; 29(3):165-71.
- de Lonlay P, Fournet JC, Rahier J, Gross-Morand MS, Poggi-Travert F, Foussier V, et al. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest. 1997; 100(4):802-7.
- Verkarre V, Fournet JC, de Lonlay P, Gross-Morand MS, Devillers M, Rahier J, et al. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest. 1998; 102(7):1286-91.
10. Stanley CA, Lieu YK, Hsu BY, Burlina AB, Greenberg CR, Hopwood NJ, et al. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med. 1998; 338(19):1352-7.
11. Thornton PS, MacMullen C, Ganguly A, Ruchelli E, Steinkrauss L, Crane A, et al. Clinical and molecular characterization of a dominant form of congenital hyperinsulinism caused by a mutation in the high-affinity sulfonylurea receptor. Diabetes. 2003; 52(9):2403-10.
12. Glaser B, Kesavan P, Heyman M, Davis E, Cuesta A, Buchs A, et al. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med. 1998; 338(4):226-30.
13. Aynsley-Green A, Dune MJ, James RF, Lindley KJ. Ions and genes in persistent hyperinsulinemic hypoglycemia in infancy: A commentary on the implications for tailoring treatment to disease pathogenesis. J Pediatr Endocrinol Metab. 1998; 11(Suppl 1):121-9.
14. Sawathiparnich P, Likitmaskul S, Angsusingha K, Nimkarn S, Chaichanwatanakul K, Laohapansang M, et al. Persistent hyperinsulinemic hypoglycemia of infancy: experience at Siriraj Hospital. J Med Assoc Thai. 2002; 85(Suppl 2):S506-12.
15. Palladino AA, Stanley CA. A specialized team approach to diagnosis and medical versus surgical treatment of infants with congenital hyperinsulinism. Semin Pediatr Surg. 2011; 20(1):32-7.
16. Yasukura K, Ono A, Woo M, Matsuzaki S, Iwase S, Kobayashi Y. A mild case of nesidioblastosis with diagnostic and therapeutic difficulty. Pediatr Int. 1993; 35(3):258-61.
Semiz S, Bircan I, Akçurin S, Mihci E, Melikoglu M, Karaguzel G, et al. Persistent hyperinsulinaemic hypoglycaemia of infancy: case report. East Afr Med J. 2002; 79(10):554-6.